Fig. 7From: A cost-effectiveness analysis model of Preventicus atrial fibrillation screening from the point of view of statutory health insurance in GermanyResult of the probabilistic sensitivity analysis: expected change in the result (Delta costs including RSA effect), timeframe lifetime (a), 4 years (b), men, base case: starting age 75 years oldBack to article page